- Report
- July 2026
- 150 Pages
Global
From €3459EUR$3,750USD£2,901GBP
- Report
- May 2026
- 350 Pages
Global
From €4565EUR$4,949USD£3,829GBP
- Report
- May 2026
- 350 Pages
Global
From €4565EUR$4,949USD£3,829GBP
- Report
- May 2026
- 138 Pages
Global
From €3689EUR$3,999USD£3,094GBP
- Report
- February 2026
- 141 Pages
Global
From €3689EUR$3,999USD£3,094GBP
- Report
- January 2026
- 147 Pages
Global
From €3644EUR$3,950USD£3,056GBP
- Report
- February 2026
- 178 Pages
Global
From €4474EUR$4,850USD£3,752GBP
- Report
- February 2026
- 188 Pages
Global
From €4474EUR$4,850USD£3,752GBP
- Report
- October 2025
- 150 Pages
Global
From €4474EUR$4,850USD£3,752GBP
- Report
- August 2026
- 160 Pages
Global
From €3063EUR$3,320USD£2,568GBP
€3828EUR$4,150USD£3,211GBP
- Report
- April 2026
- 160 Pages
Global
From €3063EUR$3,320USD£2,568GBP
€3828EUR$4,150USD£3,211GBP
- Report
- March 2026
- 104 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- September 2026
Asia Pacific
From €4427EUR$4,799USD£3,713GBP
- Report
- February 2026
- 57 Pages
Asia Pacific
From €2998EUR$3,250USD£2,514GBP
- Report
- February 2026
- 70 Pages
Europe
From €2998EUR$3,250USD£2,514GBP
- Report
- December 2025
- 81 Pages
Europe
From €2998EUR$3,250USD£2,514GBP
- Report
- December 2025
- 71 Pages
Asia Pacific
From €2998EUR$3,250USD£2,514GBP
- Report
- February 2026
- 150 Pages
United States
From €4474EUR$4,850USD£3,752GBP
- Report
- June 2026
- 370 Pages
Asia Pacific
From €1384EUR$1,500USD£1,160GBP
- Report
- October 2025
- 80 Pages
Middle East
From €4151EUR$4,500USD£3,481GBP

Biologics Development is a field of drug discovery that focuses on the development of biopharmaceuticals, which are drugs derived from living organisms. This includes proteins, peptides, nucleic acids, and other molecules. The process of biologics development involves the identification of a target molecule, the design of a drug to interact with the target, and the production of the drug. The development of biologics requires a deep understanding of the biology of the target molecule, as well as the ability to produce the drug in a cost-effective manner.
Biologics Development is a rapidly growing field, with many companies investing in the development of new biopharmaceuticals. Companies such as Amgen, Biogen, Genentech, and Novartis are leading the way in the development of biologics. Other companies such as AbbVie, AstraZeneca, and Merck are also investing in the development of biologics. These companies are working to develop new treatments for a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Show Less Read more